Page last updated: 2024-08-23

danazol and tretinoin

danazol has been researched along with tretinoin in 18 studies

Research

Studies (18)

TimeframeStudies, this research(%)All Research%
pre-19901 (5.56)18.7374
1990's4 (22.22)18.2507
2000's4 (22.22)29.6817
2010's9 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL1
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J1
Austin, CP; Fidock, DA; Hayton, K; Huang, R; Inglese, J; Jiang, H; Johnson, RL; Su, XZ; Wellems, TE; Wichterman, J; Yuan, J1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ1
Ekins, S; Williams, AJ; Xu, JJ1
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY1
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Noël, P; Solberg, LA1
Buzaid, AC; Garewal, HS; Greenberg, BR1
Krook, JA; Letendre, L; Levitt, R; Mailliard, JE; Morton, RF; Pierre, RV; Schroeder, G; Tschetter, LK1
Haase, D; Hehlmann, R; Hild, F; Lengfelder, E; Simon, M1
Azuma, H; Kanagawa, Y; Mima, N; Miyamoto, K; Saito, S; Shigekiyo, T; Shirakawa, M; Watanabe, A; Yamaguchi, H1
Fernandez, L; Hayne, O; Sadek, I; Zayed, E1
Pabinger, I; Panzer, S1
Feng, FE; Feng, R; Hou, M; Huang, XJ; Jiang, H; Jiang, Q; Liu, H; Liu, KY; Lu, J; Peng, J; Shen, JL; Wang, JW; Wang, M; Xu, LP; Zhang, JM; Zhang, XH1

Reviews

3 review(s) available for danazol and tretinoin

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
Myelodysplastic syndromes. Pathogenesis, diagnosis and treatment.
    Critical reviews in oncology/hematology, 1992, Volume: 12, Issue:3

    Topics: Antineoplastic Agents; Biomarkers; Bone Marrow Transplantation; Calcitriol; Combined Modality Therapy; Danazol; Diagnosis, Differential; Glucocorticoids; Hematopoietic Cell Growth Factors; Humans; Immunologic Factors; Incidence; Interferons; Myelodysplastic Syndromes; Prognosis; Recombinant Proteins; Tretinoin

1992
Management of myelodysplastic syndromes.
    The American journal of medicine, 1986, Volume: 80, Issue:6

    Topics: Androgens; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Cytarabine; Danazol; Glucocorticoids; Humans; Isotretinoin; Myelodysplastic Syndromes; Pyridoxal Phosphate; Pyridoxine; Tretinoin

1986

Trials

2 trial(s) available for danazol and tretinoin

ArticleYear
Myelodysplastic syndrome treatment with danazol and cis-retinoic acid.
    American journal of hematology, 1995, Volume: 48, Issue:4

    Topics: Aged; Cross-Over Studies; Danazol; Drug Administration Schedule; Female; Humans; Male; Myelodysplastic Syndromes; Prospective Studies; Tretinoin

1995
Oral all-trans retinoic acid plus danazol versus danazol as second-line treatment in adults with primary immune thrombocytopenia: a multicentre, randomised, open-label, phase 2 trial.
    The Lancet. Haematology, 2017, Volume: 4, Issue:10

    Topics: Adult; Danazol; Drug Therapy, Combination; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Odds Ratio; Platelet Count; Purpura, Thrombocytopenic, Idiopathic; Retreatment; Treatment Outcome; Tretinoin; Young Adult

2017

Other Studies

13 other study(ies) available for danazol and tretinoin

ArticleYear
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
    Current drug discovery technologies, 2004, Volume: 1, Issue:4

    Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004
Chemical genetics reveals a complex functional ground state of neural stem cells.
    Nature chemical biology, 2007, Volume: 3, Issue:5

    Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells

2007
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
    Nature chemical biology, 2009, Volume: 5, Issue:10

    Topics: Animals; Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromosome Mapping; Crosses, Genetic; Dihydroergotamine; Drug Design; Drug Resistance; Humans; Inhibitory Concentration 50; Mutation; Plasmodium falciparum; Quantitative Trait Loci; Transfection

2009
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Developing structure-activity relationships for the prediction of hepatotoxicity.
    Chemical research in toxicology, 2010, Jul-19, Volume: 23, Issue:7

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes

2010
A predictive ligand-based Bayesian model for human drug-induced liver injury.
    Drug metabolism and disposition: the biological fate of chemicals, 2010, Volume: 38, Issue:12

    Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands

2010
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
    Chemical research in toxicology, 2012, Oct-15, Volume: 25, Issue:10

    Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding

2012
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
    Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:12

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship

2012
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013
[Complete remission in acute promyelocytic leukemia. The advantages of all-trans-retinoic acid compared to conventional chemotherapy].
    Deutsche medizinische Wochenschrift (1946), 1994, Aug-26, Volume: 119, Issue:34-35

    Topics: Adult; Aminoglutethimide; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Cytarabine; Danazol; Drug Evaluation; Female; Humans; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Mitoxantrone; Prognosis; Remission Induction; Tamoxifen; Time Factors; Tretinoin

1994
An in vitro system for identifying agents capable of changing serum lipoprotein(a) concentration by regulating the transcriptional activity of the apolipoprotein(a) gene promoter.
    Biochemical and biophysical research communications, 1996, Oct-14, Volume: 227, Issue:2

    Topics: Adult; Apolipoproteins; Apoprotein(a); Base Sequence; Cell Line; Danazol; DNA; DNA Primers; Female; Gene Expression Regulation, Neoplastic; Genes, Reporter; Hepatoblastoma; Humans; Interleukin-6; Kinetics; Leukemia, Promyelocytic, Acute; Lipoprotein(a); Liver Neoplasms; Luciferases; Male; Middle Aged; Promoter Regions, Genetic; Recombinant Fusion Proteins; Transcription, Genetic; Transfection; Tretinoin; Triiodothyronine; Tumor Cells, Cultured; Vitamin E

1996
Prolonged complete remission of myelodysplastic syndrome treated with danazol, retinoic acid and low-dose prednisone.
    American journal of hematology, 2000, Volume: 64, Issue:4

    Topics: Antineoplastic Agents; Danazol; Drug Therapy, Combination; Estrogen Antagonists; Female; Humans; Middle Aged; Myelodysplastic Syndromes; Prednisone; Remission Induction; Tretinoin

2000
Is oral all-trans retinoic acid plus danazol a refinement of second-line therapy for primary immune thrombocytopenia in adults?
    The Lancet. Haematology, 2017, Volume: 4, Issue:10

    Topics: Adult; Danazol; Humans; Platelet Count; Purpura, Thrombocytopenic, Idiopathic; Thrombocytopenia; Tretinoin

2017